Innovent Announces 2023 Interim Results and Business Updates ...Middle East

Bloomberg News Today - News
Remarkable achievements with accelerated growth and improved efficiency to underpin sustainable growth ROCKVILLE, M.D. and SUZHOU, China, Aug. 23, 2023 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major diseases, announces its 2023 interim results and major company business updates. Dr. Michael Yu, Founder, Chairman and CEO of Innovent, stated: “Today is our 12th anniversary since we incorporated Innovent in 2011. Since last year, we have clearly outlined two strategic goals for the sec

Hence then, the article about innovent announces 2023 interim results and business updates was published today ( ) and is available on Bloomberg News Today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Announces 2023 Interim Results and Business Updates )

Apple Storegoogle play

Last updated :

Also on site :